HeartSciences Inc. (HSCS)
CIK 1468492 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 3.9M shares as of Jul 20, 2026 (10-K). Share count fell from 65.6M to 855,966 between Mar 14, 2024 and Jul 29, 2024, a pattern consistent with a reverse split (roughly 1-for-77); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Unit Warrants | 4.3M | $5 | — | — |
| Common Stock Warrants | 2.1M | $0.001 | 5y | — |
| Agent Unit Warrants | 57,353 | $4.375 | — | — |
| The1m Lender Warrants | 1,076 | $16 | — | — |
Tranches exactly as the company dimensioned them in its 10-K filed Jul 23, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.
Convertible notes
No convertible-note facts tagged in the 10-K filed Jul 23, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 3.9M | Jul 20, 2026 |
| + Unit Warrants (if exercised) | 4.3M | Mar 10, 2025 |
| + Common Stock Warrants (if exercised) | 2.1M | Apr 30, 2026 |
| + Agent Unit Warrants (if exercised) | 57,353 | Dec 31, 2025 |
| + The1m Lender Warrants (if exercised) | 1,076 | Nov 16, 2023 |
| Fully diluted estimate | 10.3M | +165.3% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 5 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full HSCS workspace